Clozapine treatment in a wider context: From before eligibility to life beyond clozapine
- PMID: 34622947
- DOI: 10.1111/acps.13374
Clozapine treatment in a wider context: From before eligibility to life beyond clozapine
Comment on
-
Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.Acta Psychiatr Scand. 2021 Nov;144(5):422-432. doi: 10.1111/acps.13361. Epub 2021 Aug 25. Acta Psychiatr Scand. 2021. PMID: 34374073
References
REFERENCES
-
- Siskind D, Sharma M, Pawar M, et al. Clozapine levels as a predictor for therapeutic response: a systematic review and meta-analysis. Acta Psychiatr Scand. 2021;144:422-432.
-
- Kane JM, Agid O, Baldwin ML, et al. Clinical guidance on the identification and management of treatment-resistant schizophrenia. J Clin Psychiatry. 2019;80:4-5.
-
- John AP, Ko EKF, Dominic A. Delayed initiation of clozapine continues to be a substantial clinical concern. Can J Psychiatry. 2018;63:526-531.
-
- Mizuno Y, McCutcheon RA, Brugger SP, Howes OD. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis. Neuropsychopharmacology. 2020;45:622-631.
-
- Howes OD, Kane J, Correll CU, et. al. Treatment resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2018;174:216-229.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
